Advertisement Clarient signs training and consulting agreement with Flow Cytometry Lab - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Clarient signs training and consulting agreement with Flow Cytometry Lab

Clarient, an anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, has entered into an agreement with the University of Pennsylvania School of Medicine's Flow Cytometry and Cell Sorting Resource Laboratory for a multilevel educational and technical training program.

This program is intended to provide the technical and professional staff at Clarient with the necessary skills to provide superior clinical service using both standard and non-standard assays.

The agreement offers quarterly on-site training by Flow Cytometry Lab personnel, which will include evaluating current procedures and education in specific routine processes, guidelines for clinical evaluation of hematologic malignancies, quality control and quality assurance procedures, and the development of programs to assure compliance with the state of California and the College of American Pathologists educational and professional requirements.

In addition, Flow Cytometry Lab professionals will provide on-demand consulting and technical guidance regarding equipment and educational and process issues, and will host an annual seminar on current technological topics of interest.

Michael Pellini, president and COO of Clarient, said: “We are delighted to enter into this revolutionary and invaluable educational collaboration with the Flow Cytometry Lab at UPenn. Their expertise will enable Clarient’s team to stay at the forefront of flow cytometry technology and practices. Based in one of the nation’s premiere pathology and laboratory medicine departments, the Flow Cytometry Lab will help Clarient bring the highest level of clinical services to our clients.”